ARYA Atherosclerosis Journal

Impact of Allopurinol Pretreatment on Coronary Blood Flow and Revascularization Outcomes after Percutaneous Coronary Intervention in Acute STEMI Patients: A Randomized Double Blind Clinical Trial

Volume 19, Issue 6, November and December 2023, Pages 1-9

https://doi.org/10.48305/arya.2023.11577.2121

Mohammad Kermani-Alghoraishi, MD, Hamid Sanei, Kiyan Heshmat-Ghahdarijani, Rahil Ghahramani, Mehrdad Honarvar, Masoumeh Sadeghi

• View Article
• PDF 641.44 K

The Effect of High-dose Allopurinol Pretreatment on Inflammatory Biomarkers and Post-revascularization Coronary Blood Flow in Non-STEMI Patients: A Randomized Double Blind Clinical Trial

Volume 19, Issue 4, July 2023, Pages 1-10

https://doi.org/10.48305/arya.2022.11886.2722

Hamid Sanei, Kiyan Heshmat-Ghahdarijani, Ali Asadi, Mohammad Kermani-Alghoraishi, Ali Safaei, masoumeh Sadeghi

• View Article
• PDF 638.83 K

Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial

Volume 13, Issue 5, September and October 2017, Pages 230-235

Leili Iranirad, Mohammad Saleh Sadeghi, Ahmadreza Bagheri, Kobra Doostali, Samieh Norouzi, Seyed Fakhreddin Hejazi, Hossein Saghafi, Sakineh Roshani-Mobaraki

• View Article
• PDF 371.6 K